Citi Research

RHB upgrades CICT to 'buy' following 3QFY2022 update, Citi keeps 'buy' - THE EDGE SINGAPORE

Broker's Calls

RHB upgrades CICT to 'buy' following 3QFY2022 update, Citi keeps 'buy'

RHB Group Research and Citi Research have given CICT TPs of $2 and $2.35 respectively.
Citi Research downgrades MINT to 'neutral' with lowered TP of $2.22 - THE EDGE SINGAPORE

Broker's Calls

Citi Research downgrades MINT to 'neutral' with lowered TP of $2.22

Within the industrial Singapore REIT (S-REIT) sector, Lee has indicated his preference for CapitaLand Ascendas REIT.

Broker's Calls

Citi upgrades StarHub to 'neutral' due to undemanding valuations on the back of share price correction

“Our target price remains unchanged at $1.16, with our upgrade driven by StarHub’s share price correction," says Citi's Pineda.

Broker's Calls

Analysts keep 'buy' on Nanofilm as it sees 'significant runway' for company to capture new customers

UOB Kay Hian, DBS Group Research and Citi Research have all kept their "buy" calls on Nanofilm.
Is Grab still grabworthy? - THE EDGE SINGAPORE

Broker's Calls

Is Grab still grabworthy?

Following Grab's investor day, analysts seem to be able to see the light at the end of the tunnel for Grab.

Broker's Calls

Analysts expect authorities to revise inflation forecasts upwards; MAS may tighten monetary policy in October

Singapore's headline inflation stood at 7.5% y-o-y while core inflation stood at 5.1% y-o-y in August 2022.

Broker's Calls

Parkway Life REIT’s Japan acquisitions likely to boost DPU: analysts

CGS-CIMB's Lock Mun Yee has kept her target price at $5.06, while Citi’s Brandon Lee has maintained his target price of $5.02.

Broker's Calls

Citi downgrades MLT from ‘buy’ to ‘neutral’ considering benign forward DPU growth

MLT traded at 1.3x P/B from FY2017-FY2021 when acquisition per year was $1.2 billion.
×